About NDM

NDM Research Building

The Nuffield Department of Clinical Medicine is part of the Medical Sciences Division. It hosts one of the largest groupings of Biomedical Researchers in the University Sector, and is also responsible for a significant part of the teaching of clinical medical students with the Oxford Medical School.


Welcome event for research staff

Welcome event for research staff

Posted 26/01/2015

Friday 13 February, 9.30-12.30 pm, Richard Doll Building, Old Road Campus. If you have recently joined the University as a member of research staff (postdoc, research fellow, research assistant etc, employed at Grade 6 or above), this event is an opportunity for you to find out about career and professional development opportunities, the services and support available for you throughout your time as a researcher here at Oxford, and to meet other new researchers from departments in the University over coffee and pastries.

View all events

Summer internships


Applications are now open for the 2015 Summer Internship Programme.

View podcast

Latest News

Genetics underpinning artemisinin resistance revealed

Genetics underpinning artemisinin resistance revealed

Posted 19/01/2015

NDM researchers have led the largest genome-wide association study to date of the malaria parasite Plasmodium falciparum. The new study published in Nature Genetics unveils a complex genetic architecture that enables the parasite to develop resistance to our most effective antimalarial drug, artemisinin. The results could help to improve early detection of emerging artemisinin resistance. The global research collaboration analysed 1612 samples from 15 locations in Southeast Asia and Africa and found 20 mutations in the kelch13 gene, a known ...

Ebola research in NDM

Ebola research in NDM

Posted 07/01/2015

A clinical trial of a potential treatment for Ebola has started in Liberia, with the first Ebola patient receiving the study drug on 2 January. Funded by the Wellcome Trust, the trial aims to evaluate the effectiveness of an oral antiviral drug called brincidofovir in patients with Ebola virus disease. Brincidofovir is an experimental drug made by the US company Chimerix in Durham, North Carolina Professor Peter Horby the trial's chief Investigator, says: 'I'm delighted that the trial has started. It is a tribute to the momentous efforts of ...

News Archive

Podcast: Meet the Researchers



Ian Tomlinson, Professor of Molecular and Population Genetics at the Wellcome Trust for Human Genetics, works on the identification of genes that predispose to colorectal and other cancers. His research focuses on the relative importance of selection and genomic instability.

View Podcast

Medical Grand Rounds


Thursday 5th Feb, Lecture Theatre 1, John Radcliffe Hospital, 13:00 to 14:00

Acute General Medicine – Firm C: "A cytokine storm is brewing", Dr Phil Mathieson, Dr Kiran Bangalore, Dr Graham Collins and Dr Faye Sharpley

Oncology: "The Oxford Cancer Imaging Centre Programme: Using Imaging to Change the Treatment of Cancer", Dr Ricky Sharma and Prof Fergus Gleeson

Chair: Prof Sir Peter J Ratcliffe FRS

See upcoming Medical Grand Rounds